key: cord-0685357-1i01g4pl
authors: Griesemer, S. B.; Van Slyke, G.; Ehrbar, D.; Strle, K.; Yildirim, T.; Centurioni, D. A.; Walsh, A. C.; Chang, A. K.; Waxman, M. J.; St. George, K.
title: Evaluation of specimen types and saliva stabilization solutions for SARS-CoV-2 testing
date: 2020-06-18
journal: nan
DOI: 10.1101/2020.06.16.20133041
sha: f71a66e5c156d98e5605c7564ec0507c9879cc00
doc_id: 685357
cord_uid: 1i01g4pl

Identifying SARS-CoV-2 infections through aggressive diagnostic testing remains critical in tracking and curbing the spread of the COVID-19 pandemic. Collection of nasopharyngeal swabs (NPS), the preferred sample type for SARS-CoV-2 detection, has become difficult due to the dramatic increase in testing and consequential supply strain. Therefore, alternative specimen types have been investigated, that provide similar detection sensitivity with reduced health care exposure and potential for self-collection. In this study, the detection sensitivity of SARS-CoV-2 in nasal swabs (NS) and saliva was compared to that of NPS, using matched specimens from two outpatient cohorts in New York State (total n = 463). The first cohort showed only a 5.4% positivity but the second cohort (n=227) had a positivity rate of 41%, with sensitivity in NPS, NS and saliva of 97.9%, 87.1%, and 87.1%, respectively. Whether the reduced sensitivity of NS or saliva is acceptable must be assessed in the settings where they are used. However, we sought to improve on it by validating a method to mix the two sample types, as the combination of nasal swab and saliva resulted in 94.6% SARS-CoV-2 detection sensitivity. Spiking experiments showed that combining them did not adversely affect the detection sensitivity in either. Virus stability in saliva was also investigated, with and without the addition of commercially available stabilizing solutions. The virus was stable in saliva at both 4C and room temperature for up to 7 days. The addition of stabilizing solutions did not enhance stability and in some situations reduced detectable virus levels.

Identifying acute COVID-19 infection through diagnostic testing and screening remains critical 46 in our efforts to care for affected patients and curb the pandemic. Accordingly, laboratory 47 services have worked to expand testing capacity, improve turnaround times, track the course of 48 the outbreak, and provide data for patient management and the implementation of appropriate 49 mitigation efforts and healthcare services (1).

The original standard for diagnosing COVID-19 was molecular testing for SARS-CoV-2 RNA 52 on a nasopharyngeal swab (NPS) collected in virus transport medium (VTM). Unfortunately, 53 performing NPS necessitates the use of a specifically designed swab and requires health care 54 workers to wear extensive personal protective equipment (PPE) . Within weeks of the pandemic 55 onset in the US, multiple aspects of the specimen collection and testing process became 56 extremely difficult. The desired testing capacity quickly exceeded anything attempted in the 57 country before and vendors were unable to meet the supply demands for all required sampling 58 components including the specific swabs used for NPS specimen collection, VTM, PPE, 59 reagents, and instruments needed for testing the samples at the laboratories (1-6). In response, a 60 number of changes were implemented: guidelines were rapidly changed to require clinicians to 61 limit the use of (or to reuse) PPE (4, 7-9), alternatives to VTM were tested and implemented (10-62 12), and numerous additional commercial diagnostic tests and instruments were authorized and 63 distributed by the U.S Food and Drug Administration (https://www.fda.gov/emergency-64 preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-65 authorization#covid19euas). Additionally, other sample types were assessed as alternatives to 66 NPS. (3, (13) (14) (15) (16) (17) (18) (19) 67 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020 . . https://doi.org/10.1101 4 68 Testing of oropharyngeal swabs (OPS), nasal swabs (NS), mid-turbinate swabs (MTS) and saliva 69 provided the opportunity to be less restrictive about the type of swab used, and the last three 70 options also offer the additional advantage of self-collection. This has been demonstrated to be 71 successful in previous studies on influenza detection, where self-collected specimens were found 72 to have similar detection rates as those collected by health care personnel (20, 21). Major 73 advantages of self-collection include limiting the exposure of health care workers to potentially 74 infected patients, subsequently reducing usage of PPE, as well as limiting the exposure of 75 patients to hospitals where infection is likely more prevalent. Self-collection also allows for 76 individuals to conveniently test themselves at home, which could lead to increased testing rates 77 with a limited burden on health care systems.

Numerous recent studies have therefore focused on the comparative sensitivity of upper 80 respiratory swabs other than NPS, which has long been considered the preferred option for 81 optimal detection of most respiratory viruses (3, 15, 19, 22) . Experience with saliva as a 82 diagnostic sample type for respiratory viruses has been limited, although in recent weeks, several 83 studies have suggested saliva to be of acceptable or equal sensitivity to NPS or other specimen 84 types for the diagnosis of 17, 18, 23, 24) . Some studies have also proposed 85 the use of saliva stabilizing solutions and it has been unclear as to whether these are necessary or 86 advantageous.

In this study, nasal swabs and saliva were compared to NPS for the detection of SARS-CoV-2 in 89 outpatients from two distinct New York populations, one of which had high prevalence while the 90 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 18, 2020 . . https://doi.org/10.1101 other had low. The stability of SARS-CoV-2 in saliva and the utility of three stabilizing solutions 91 were investigated. Finally, methods for combining swabs and saliva in the laboratory were 92 assessed to maximize detection of the virus without running multiple tests when more than one 93 specimen type is collected. not required to be symptomatic. No patients were excluded. The second testing site was a drive-105 through Regional Operations Center in New Rochelle (NR), NY, where an identified "super-106 spreader" event had taken place early in the pandemic and the COVID-19 positivity rate was 107 known to be high. Patients were required to have an appointment and qualifying symptoms or 108 exposures; 227 subjects were enrolled from this site. Three specimens were collected from each subject: nasopharyngeal swab, nasal swab, and 112 saliva. Nasal swab and NPS were placed in separate tubes containing 1 ml Molecular Transport 113 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 18, 2020. 

Saliva specimens with excessive mucus were digested prior to extraction with Snap n' Digest 124 (Scientific Device Laboratory, Des Plaines, IL); briefly, 0.5-1 ml of Snap n' Digest was added to 125 each saliva specimen based on sample volume, vortexed and allowed to digest for 10 minutes.

The CDC 2019 nCoV Real-Time RT-PCR Diagnostic Panel (25-27) was used to test all samples.

Total nucleic acid extraction was conducted on the bioMerieux easyMAG ® or EMAG ® 128 (bioMerieux Inc, Durham, NC); briefly, for all individual specimens tested, 110μL of the sample 129 was added to 2mL NucliSENS Lysis Buffer (bioMerieux) and extracted into 110μL of eluate.

Testing was performed on ABI 7500FAST Dx instruments as described in the instructions for CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10.1101/2020.06.16.20133041 doi: medRxiv preprint 8 Combined saliva and nasal swab as a single specimen 159 To investigate the possibility of maximizing virus detection without doubling the number of tests 160 performed, mixed saliva and nasal swabs were validated as a sample type in the following 161 manner: 110uL of each specimen was added to the same 2mL lysis buffer tube, eluted into 162 110uL and tested as one sample. To mimic situations in which saliva is positive and nasal swabs 163 are negative, or vice-versa, and confirm that there is no adverse impact on the detection, LODs 164 were determined for spiked combined specimens. Saliva stabilizing experiments 176 To evaluate the stability of SARS-CoV-2 in saliva and to determine the necessity of stabilizing 177 solutions for virus preservation in saliva, infectious SARS-CoV-2 virus was spiked into pooled 178 negative saliva and sampled at multiple timepoints, with storage at multiple temperatures, with 179 and without the addition of various stabilizing buffers. Individual saliva specimens were tested 180 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10.1101/2020.06.16.20133041 doi: medRxiv preprint for SARS-CoV-2 by real-time RT-PCR before using in stability studies to verify their negative 181 status. Table 1 summarizes the multiple parameters assessed in the stabilizing experiments.

SARS-CoV-2 isolate USA-WA1/2020, cultured and harvested as described above, was used in 183 all stabilizing experiments. Stock viral RNA concentration was calculated at 2.2x10 7 RNA gene 184 copies/uL as described above. Stock virus was diluted in EMEM + 2% FBS to working 185 concentrations and samples in each experiment were spiked with either high (1x10 6 RNA 186 copies/mL specimen or 5000 RNA copies/PCR reaction) or low (2x10 5 RNA copies/mL 187 specimen, or 200 RNA copies/PCR reaction) concentrations in duplicate. Individual saliva 188 specimens were tested for SARS-CoV-2 by real-time RT-PCR before using in stability studies.

Sampling of all specimens for the stability studies included lysis of 110uL specimen into 2mL with 110uL transfer to lysis buffer tubes as described above. Duplicate tubes at each 203 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10.1101/2020.06.16.20133041 doi: medRxiv preprint concentration were then stored at room temperature, 4 o C, and -80 o C, and samples tested at each 204 of days 1, 3, 5 and 7, except for those stored at -80 o C, which were only analyzed at day seven. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10.1101/2020.06.16.20133041 doi: medRxiv preprint with low virus and four remained un-spiked. Two of each of these four (2 high, 2 low, 2 no 227 virus) were then mixed with AcD stabilization buffer. Six NS tubes were also spiked with high, 228 low, or no virus. Tubes were incubated at room temperature and sampling was performed at 229 three timepoints: days 0, 1.5, and 3. At each time point, 110uL from each of the tubes was 230 removed, lysed, extracted and analyzed. In addition, 110uL of each prepared saliva sample, with 231 and without stabilization buffer, was lysed together with 110uL of each prepared nasal swab 232 sample, so that high, low, and negative saliva samples would be mixed with high, low, and CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. 

Patient demographics and regional positivity rates 254 Specimens were collected from a total of 463 individuals at two collection sites in New York Table 2 . Of the 227 patients tested at that site, 93 (41%) were positive for SARS-CoV- between Ct values from NPS and saliva specimens with age were found (data not shown).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. 274 We sought to determine whether NS or saliva specimens could be used as a surrogate sample with overlapping 95% confidence intervals (Table 3) . Both NS and saliva had lower, and 284 identical, sensitivities and 95% confidence intervals (87.1% and 79.57-93.55 for both) than either 285 NPS or the combination of NS and saliva. The confidence intervals for NS and saliva 286 overlapped with that for the NS and saliva combination specimen type, but not with NPS 287 specimen type (Table 3) . found to be 25 RNA copies/PCR reaction or 5 RNA copies/µL on both extraction platforms.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10.1101/2020. 06.16.20133041 doi: medRxiv preprint Additionally, clinical evaluation studies of all specimen types with amended negative samples 295 showed 100% accuracy (data not shown). 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020 . . https://doi.org/10.1101 An initial experiment compared the deterioration of virus in spiked saliva, stabilized by the 318 addition of VTM, to that of spiked saliva with the stabilization buffer from 23andMe ® . Samples 319 were stored at 4°C and room temperature and tested at days 0, 1, 3, 5 and 7. The SARS-CoV-2 320 virus in saliva was more stable in VTM than in 23andMe ® stabilizing solution, as indicated by Ct 321 values over time at either temperature ( Figure 5 ). Greatest losses in detectable viral RNA were 322 seen at day 7 in saliva with 23andMe ® stabilizing solution, particularly in samples that had been CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020 . . https://doi.org/10.1101 high level virus in the nasal swab), C) the presence of saliva does not impact the detection of low 341 or high level virus spiked into nasal swab. All these findings are consistent across the three days In the study reported here, the results show that in the outpatient group tested, that is not severely 361 ill, NPS specimens produced greatest sensitivity at approximately 98%, while NS or saliva alone 362 provided sensitivities of approximately 87%. Whether the reduction in detection sensitivity that 363 occurs with the use of these specimen types is acceptable has to be assessed in the settings in 364 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10.1101/2020.06.16.20133041 doi: medRxiv preprint which they are being used, taking into account the more ready availability of NS swabs, the 365 convenience of collection, the reduced discomfort of NS and saliva collection, as well as the 366 potential for self-collection of these specimens and thus diminished risk of transmission to health 367 care personnel. Notably, some other studies have not found sensitivity differences this great, 368 while others have found them more extreme (13, 14, 16, 18, 19, 24, A. L. Wylie et al. submitted 369 for publication). By combining the NS and saliva specimens in the laboratory, we were able to 370 increase sensitivity to 95%, an additional 8% above NS or saliva alone; we believe this to be a 371 substantial improvement and a beneficial option for sensitive diagnosis of SARS-CoV-2.

Of note, we did find that many of the submitted saliva specimens from NR were excessively 374 mucoid, clearly containing material that had been coughed into the specimen and had to be 375 digested, similar to the process used for sputum. Following this experience, we issued strict 376 instructions not to cough or do anything that would result in excess mucus in the sample, but to 377 dribble or gently spit into the collection tube. In some other publications the term "saliva" has 378 been used loosely and on reading the specimen description carefully, has clearly included the 379 deliberate collection of mucus. It is unclear from descriptions in most of the published papers 380 where saliva has been studied, however, if they were truly saliva specimens or if they were a 381 combination of saliva and "sputum" and what the relative sensitivity of the two specimen types 382 is for detecting SARS-CoV-2. Saliva does present an attractive alternative to both NPS and NS 383 specimens because the only collection consumable needed is a tube. Notably this sampling 384 strategy has limitations: it may not be suitable for children, mentally challenged patients, or 385 severely ill patients. The collection of saliva is clearly not suitable for intubated patients and the 386 use of alternative sample types should be continued for those situations.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020 . . https://doi.org/10.1101 18 388 Saliva contains many antibodies and enzymes that could ultimately affect the stability of virus 389 particles or viral RNA, which could impede detection. In our sample comparison from the NR 390 cohort, significantly lower Ct values were observed in saliva samples than those in NS or NPS. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020 . . https://doi.org/10.1101 on the relative sensitivities of various specimen types in asymptomatic individuals and they may 411 be quite different from the symptomatic populations tested and reported on so far. Thus, the 412 findings of our study, that the combination of NS and saliva provide similar sensitivity to NPS 413 while alleviating many of its limitations, should be carefully considered based on the setting and 414 the study population being tested. 444 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. Mixtures of saliva plus 23andMe ® buffer (blue) or VTM (purple) and virus were held at either room temperature (A, dashed lines) or 4°C (B, solid lines) and sampled at days 0, 1, 3, 5, and 7, in duplicate. Mean Ct values for N1 were plotted, and simple linear regression analysis performed. The slope of all VTM curves did not deviate significantly from zero; the slope of 23andMe ® lo spike at 4°C did not deviate significantly from zero, the slope of all other 23andMe ® plots significantly deviated from zero (P<0.02). CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 18, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 18, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 18, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10. 1101 

Value of Diagnostic Testing for SARS-CoV-2/COVID-19

COVID-19 and risks to the supply and 481 quality of tests, drugs, and vaccines

Sampling for SARS-CoV-2: a Convenient Alternative in Times of Nasopharyngeal Swab 485 Shortage

Challenges and solutions for addressing critical shortage of 487 supply chain for personal and protective equipment (PPE) arising from Coronavirus 488 disease (COVID19) pandemic -Case study from the Republic of Ireland

Comparison of Copan ESwab and FLOQSwab

Diagnosis: Working around a Supply Shortage

An international comparison analysis of reserve and 13

Saliva samples as an 519 alternative for novel coronavirus (COVID-19) diagnosis

Saliva is a 523 reliable tool to detect SARS-CoV-2

A 525 combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for 526 the detection of SARS-CoV-2

Validation of SARS-CoV-2 detection across multiple specimen 529 types

Detection of SARS-CoV-2 RNA and 532

Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-533

Home-Collected Blood, Saliva, and Oropharyngeal Samples

Detection of SARS-associated coronavirus in throat 539 wash and saliva in early diagnosis

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted

Self-collected compared with 544 professional-collected swabbing in the diagnosis of influenza in symptomatic individuals: 545 A meta-analysis and assessment of validity

Self-Swabbing for Virological Confirmation of 548

Influenza-Like Illness Among an Internet-Based Cohort in the UK During the

Additional molecular testing of saliva specimens improves the 552 detection of respiratory viruses

Saliva sample as a non-invasive 555 specimen for the diagnosis of coronavirus disease-2019 (COVID-19): a cross-sectional 556 study

Consistent detection of 2019 novel coronavirus in saliva

The authors thank 23andMe ® and Ancestry ® for their generous provision of the saliva collection 418 kits used in this work, participation in discussions regarding the experiments and their scientific

openness regarding the findings. We also thank the staff of the Virology Laboratory at the 420 Wadsworth Center for processing and testing the additional 1500 specimens for the initial phase 421 of this study at a time when testing services were already stretched to capacity. The authors 422 thank Scott Wies, Peter Inglis, Akshay Vig, Kevin Flatley, and Druv Patel for assistance with 423 specimen collection at the AMC site, as well as the nurses and aids who staffed and collected 424 specimens in the AMC tent. We also thank Alan Antenucci for coordinating retrieval of samples 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10.1101/2020.06.16.20133041 doi: medRxiv preprint 32 Infect Dis doi:10.1093/cid/ciaa149.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 18, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted June 18, 2020. . https://doi.org/10. 1101